Epitalon FDA Status 2026: Epitalon and Emideltide (DSIP) at the PCAC Review, What Researchers Need to Know
The epitalon fda status 2026 update has become a major talking point in the longevity and anti aging research community, and it is arriving alongside a related story about a different peptide, Emideltide, also known as DSIP. These are two separate compounds, but they share the same regulatory spotlight because both are on the FDA's July 24 review calendar. In Lab Peptides has been tracking every update on this docket, and this guide breaks down what changed, what these two peptides actually are, and what the upcoming hearing could mean for researchers.






